David-Alexandre Gros
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $613,196 | $3,216,148 |
| 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $582,269 | $5,644,970 |
| 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $559,478 | $2,553,153 |
| 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $532,503 | $1,118,493 |
| 2021 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $503,654 | $747,504 |
| 2020 | Eledon Pharmaceuticals, Inc. (ELDN) | Chief Executive Officer | $150,000 | $7,419,307 |
Earnings-call appearances
-
Eledon Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-11
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-30
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-14
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-11
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-03-24
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-12
Eledon Pharmaceuticals, Inc. (ELDN)
-
Eledon Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-13
Eledon Pharmaceuticals, Inc. (ELDN)